Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of MBP8298 in relapsing remitting multiple sclerosis
2006-001947-70Phase 2Completed
- Sponsor
- BioMS Medical Corp.
- Start
- Aug 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing MBP8298 with Placebo (2 arms). Primary endpoints: Annualized relapse rate at 12 months in HLA DR2/4-positive subjects and Safety in HLA DR2/4-positive subjects. Started Aug 2006; status: completed.
02
Drugs
dirucotide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-001947-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001947-70.